|
1
|
Choy MC, Seah D, Faleck DM, Shah SC, Chao
CY, An YK, Radford-Smith G, Bessissow T, Dubinsky MC, Ford AC, et
al: Systematic review and meta-analysis: Optimal salvage therapy in
acute severe ulcerative colitis. Inflamm Bowel Dis. 25:1169–1186.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cosnes J, Gower-Rousseau C, Seksik P and
Cortot A: Epidemiology and natural history of inflammatory bowel
diseases. Gastroenterology. 140:1785–1794. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Molodecky NA, Soon IS, Rabi DM, Ghali WA,
Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema
HW and Kaplan GG: Increasing incidence and prevalence of the
inflammatory bowel diseases with time, based on systematic review.
Gastroenterology. 142:46–54.e42.e30. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bernstein CN, Ng SC, Lakatos PL, Moum B
and Loftus EV Jr: Epidemiology and Natural History Task Force of
the International Organization of the Study of Inflammatory Bowel
Disease: A review of mortality and surgery in ulcerative colitis:
Milestones of the seriousness of the disease. Inflamm Bowel Dis.
19:2001–2010. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kaplan GG, Seow CH, Ghosh S, Molodecky N,
Rezaie A, Moran GW, Proulx MC, Hubbard J, MacLean A, Buie D and
Panaccione R: Decreasing colectomy rates for ulcerative colitis: A
population-based time trend study. Am J Gastroenterol.
107:1879–1887. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Head KA and Jurenka JS: Inflammatory bowel
disease Part 1: Ulcerative colitis-pathophysiology and conventional
and alternative treatment options. Altern Med Rev. 8:247–283.
2003.PubMed/NCBI
|
|
7
|
Mansfield JC, Holden H, Tarlow JK, Di
Giovine FS, McDowell TL, Wilson AG, Holdsworth CD and Duff GW:
Novel genetic association between ulcerative colitis and the
anti-inflammatory cytokine interleukin-1 receptor antagonist.
Gastroenterology. 106:637–642. 1994.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Russell SE, Horan RM, Stefanska AM, Carey
A, Leon G, Aguilera M, Statovci D, Moran T, Fallon PG, Shanahan F,
et al: IL-36α expression is elevated in ulcerative colitis and
promotes colonic inflammation. Mucosal Immunol. 9:1193–1204.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cătană CS, Berindan Neagoe I, Cozma V,
Magdaş C, Tăbăran F and Dumitraşcu DL: Contribution of the
IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
World J Gastroenterol. 21:5823–5830. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mirza AH, Berthelsen CH, Seemann SE, Pan
X, Frederiksen KS, Vilien M, Gorodkin J and Pociot F:
Transcriptomic landscape of lncRNAs in inflammatory bowel disease.
Genome Med. 7(39)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Padua D, Mahurkar-Joshi S, Law IK,
Polytarchou C, Vu JP, Pisegna JR, Shih D, Iliopoulos D and
Pothoulakis C: A long noncoding RNA signature for ulcerative
colitis identifies IFNG-AS1 as an enhancer of inflammation. Am J
Physiol Gastrointest Liver Physiol. 311:G446–G457. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Du M, Yuan L, Tan X, Huang D, Wang X,
Zheng Z, Mao X, Li X, Yang L, Huang K, et al: The LPS-inducible
lncRNA Mirt2 is a negative regulator of inflammation. Nat Commun.
8(2049)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Feakins RM: British Society of
Gastroenterology: Inflammatory bowel disease biopsies: Updated
British Society of Gastroenterology reporting guidelines. J Clin
Pathol. 66:1005–1026. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pott J, Kabat AM and Maloy KJ: Intestinal
epithelial cell autophagy is required to protect against
tnf-induced apoptosis during chronic colitis in mice. Cell Host
Microbe. 23:191–202.e194. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang SQ, Ni WK, Xiao MB, Jiang F, Lu CH,
Wang RH and Ni RZ: Actin related protein 3 (ARP3) promotes
apoptosis of intestinal epithelial cells in ulcerative colitis.
Pathol Res Pract. 215:235–242. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11(59)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cario E, Rosenberg IM, Brandwein SL, Beck
PL, Reinecker HC and Podolsky DK: Lipopolysaccharide activates
distinct signaling pathways in intestinal epithelial cell lines
expressing Toll-like receptors. J Immunol. 164:966–972.
2000.PubMed/NCBI View Article : Google Scholar
|
